Leap Therapeutics
Douglas Onsi is an accomplished executive with extensive experience in the biotech and pharmaceutical sectors. Currently serving as the Chief Executive Officer and CFO at Leap Therapeutics, Douglas has previously held leadership roles including Managing Director at HealthCare Ventures LLC, VP of Business Development at Genzyme Corporation, CFO at TolerRx, Inc., and Assistant Director of Business Development at Millennium Pharmaceuticals, Inc. Douglas Onsi holds a Bachelor of Science degree in Biology from Cornell University and a Juris Doctor degree from the University of Michigan.
This person is not in any teams
This person is not in any offices
Leap Therapeutics
1 followers
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.